Skip to main content

CORRECTION article

Front. Immunol.
Sec. Cancer Immunity and Immunotherapy
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1536312

Corrigendum:Research progress of CD80 in the development of immunotherapy drugs

Provisionally accepted
Lei Yang Lei Yang 1Li Lanying Li Lanying 2De Peng Jiang De Peng Jiang 1*
  • 1 Second Affiliated Hospital, Chongqing Medical University, Chongqing, China
  • 2 Institute of Cancer, Xinqiao Hospital, Army Medical University, Chongqing, China

This article is a correction to:

  1. Research progress of CD80 in the development of immunotherapy drugs

    1. Read original article

The final, formatted version of the article will be published soon.

    CD80 is a molecule that plays an important role in the immune system, especially during T-cell activation, and its ligands are mainly CD28, PD-L1, and CTLA-4. CD80 is expressed on the surface of tumor cells, and it can be used as a molecular target in the process of T-cell anti-tumor immune response. In autoimmune diseases, CD80 can also regulate autoimmune diseases by modulating immunity. This review mainly focus on the role of CD80 in the immune system, as well as the research progress on the application of CD80- related immunopharmaceuticals in the treatment of tumors and autoimmune diseases.

    Keywords: CD80, immunotherapy drugs, T cells, tumor, Autoimmune Diseases

    Received: 28 Nov 2024; Accepted: 29 Nov 2024.

    Copyright: © 2024 Yang, Lanying and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: De Peng Jiang, Second Affiliated Hospital, Chongqing Medical University, Chongqing, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.